Quest Partners LLC trimmed its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 10.3% during the third quarter, ...

On Friday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $140.14 which represents a slight increase of $3.15 or 2.30% from the prior close of $136.99. The stock opened at $137.77 ...

Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth ...

On Tuesday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $135 which represents a slight increase of $4.26 or 3.26% from the prior close of $130.74. The stock opened at $130.11 and ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Morgan Stanley reiterated their equal weight rating on shares of Illumina (NASDAQ:ILMN – Free Report) in a research note ...

Morgan Stanley analyst Tejas Savant has maintained their neutral stance on ILMN stock, giving a Hold rating on November 6 ... Baird also maintained a Hold rating on the stock with a $139.00 price ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Utilizing one-week price change and the monthly percentage ... diagnostic and consumer genomics companies. ILMN is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of A and VGM Score ...

The data does tell us to set a stop loss 148.49 to protect against excessive loss in case the stock begins to move against the trade. 148.92 is the first level of support below 151.09, and by rule, ...